Most sold healthcare stocks in Q3 2021

See which Healthcare stocks institutional investors trimmed or exited the most in Q3 2021, measured as net reductions in reported share positions from Q2 2021 into Q3 2021. Notable reductions at the top of this list include ZOMEDICA CORP (ZOM), AGILENT TECHNOLOGIES INC (A), BRISTOL-MYERS SQUIBB CO (BMY), SERES THERAPEUTICS INC (MCRB). These rankings are based on SEC 13F filings from the investors we track.

SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
ZOMZOMEDICA CORP-13,371,960-$11.14K00011
AAGILENT TECHNOLOGIES INC-11,613,444-$1.65M11225
BMYBRISTOL-MYERS SQUIBB CO-10,612,720-$7.86M049215
MCRBSERES THERAPEUTICS INC-9,713,160-$231.66K00010
MRKMERCK & CO. INC.-7,787,811-$617.21K073114
IOVAIOVANCE BIOTHERAPEUTICS INC-6,800,876-$192.80K00101
BSXBOSTON SCIENTIFIC CORP-5,993,449-$242.06K11104
ABBVABBVIE INC-5,765,057-$374.11K054211
RHHBYROCHE HOLDINGS LTD-SPONS ADR-5,001,511-$235.02K00101
BDXBECTON DICKINSON AND CO-4,493,940-$968.71K055112
CERSCERUS CORP-4,169,929-$21.55K00202
AVTRAVANTOR INC-3,857,691-$8.71K02103
CVSCVS HEALTH CORP-2,953,230-$222.81K035110
WBAWALGREENS BOOTS ALLIANCE INC-2,679,296-$158.49K01224
NVONOVO-NORDISK A/S-SPONS ADR-2,543,277$51.96K00113
OCGNOCUGEN INC-2,429,500-$19.52K00101
TAKTAKEDA PHARMACEUTIC-SP ADR-2,255,713-$45.87K00303
TEVATEVA PHARMACEUTICAL-SP ADR-2,206,663-$34.17K00305
ZTSZOETIS INC-2,063,746$9.80M036010
UNHUNITEDHEALTH GROUP INC-1,890,718$3.77M1514221
MRNAMODERNA INC-1,863,956$358.85K10213
SEERSEER INC-1,572,418-$51.54K00020
AMRNAMARIN CORP PLC -ADR-1,413,000-$6.19K00010
CYHCOMMUNITY HEALTH SYSTEMS INC-1,277,800-$23.09K10102
IRWDIRONWOOD PHARMACEUTICALS INC-1,228,500-$15.39K00101
CNCCENTENE CORP-1,222,845-$195.25K10112
TWSTTWIST BIOSCIENCE CORP-1,108,455-$251.41K00101
TXG10X GENOMICS INC-CLASS A-1,105,670-$381.68K10103
IONSIONIS PHARMACEUTICALS INC-1,075,049-$97.55K00202
BHCBAUSCH HEALTH COS INC-1,041,190-$113.67K00215
EDITEDITAS MEDICINE INC-1,022,696-$155.91K00111
CTXRCITIUS PHARMACEUTICALS INC-1,009,850-$4.80K00101
OGNORGANON & CO-1,004,385$110.90K21225
XRAYDENTSPLY SIRONA INC-895,651-$98.55K00303
AKBAAKEBIA THERAPEUTICS INC-877,803-$4.19K00101
CLLSCELLECTIS - ADR-876,255-$24.37K00101
PHGKONINKLIJKE PHILIPS NVR- NY-868,712-$43.64K00101
VTRSVIATRIS INC-862,152-$128.21K01213
CDXSCODEXIS INC-860,778-$16.00K00111
CDNACAREDX INC-855,057-$182.66K10102
HOLXHOLOGIC INC-846,352-$49.39K01304
EVHEVOLENT HEALTH INC - A-805,861$63.44K00202
MCKMCKESSON CORP-779,874-$124.36K00212
PGENPRECIGEN INC-760,560-$17.96K10102
TMOTHERMO FISHER SCIENTIFIC INC-751,068-$224.35K02519
BFLYBUTTERFLY NETWORK INC-740,321-$39.77K00101
ALLOALLOGENE THERAPEUTICS INC-704,400-$18.37K00010
ASRTASSERTIO HOLDINGS INC-681,585-$1.06K00010
NTLAINTELLIA THERAPEUTICS INC-636,446-$325.77K01102
MRNSMARINUS PHARMACEUTICALS INC-625,000-$11.21K00010
20 symbols with net change in reported shares from tracked managers.−14.7M−11.0M−7.4M−3.7M0.00Net change in reported shares (tracked managers)ZOMABMYMCRBMRKIOVABSXABBVRHHBYBDXCERSAVTRCVSWBANVOOCGNTAKTEVAZTSUNHSymbol

Frequently asked questions about Most sold healthcare stocks in Q3 2021

  • What are the most sold Healthcare stocks in Q3 2021?

    The most sold healthcare stocks in Q3 2021 are those with the largest decrease in reported share counts across tracked institutional investors compared to Q2 2021, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors trimmed or exited the most in Q3 2021?

    Among the managers we track, net reductions were largest in companies such as ZOMEDICA CORP (ZOM), AGILENT TECHNOLOGIES INC (A), BRISTOL-MYERS SQUIBB CO (BMY), based on aggregated 13F data.

  • How is institutional selling calculated?

    Selling is calculated by summing the net decrease in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q2 2021).

  • Does this include all institutional owners?

    These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.